GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM (CAS:PRO) » Definitions » Interest Coverage

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM (CAS:PRO) Interest Coverage : 9.28 (As of Dec. 2024)


View and export this data going back to 2007. Start your Free Trial

What is PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Operating Income for the six months ended in Dec. 2024 was MAD51.7 Mil. PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Interest Expense for the six months ended in Dec. 2024 was MAD-5.6 Mil. PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's interest coverage for the quarter that ended in Dec. 2024 was 9.28. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Interest Coverage or its related term are showing as below:

CAS:PRO' s Interest Coverage Range Over the Past 10 Years
Min: 9.49   Med: 70.87   Max: 1079.52
Current: 9.49


CAS:PRO's Interest Coverage is ranked worse than
55.57% of 655 companies
in the Drug Manufacturers industry
Industry Median: 11.98 vs CAS:PRO: 9.49

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Interest Coverage Historical Data

The historical data trend for PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Interest Coverage Chart

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Coverage
Get a 7-Day Free Trial Premium Member Only 1,079.52 332.87 94.43 21.75 9.49

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Semi-Annual Data
Jun15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Interest Coverage Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 86.63 28.37 18.57 9.73 9.28

Competitive Comparison of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Interest Coverage

For the Drug Manufacturers - Specialty & Generic subindustry, PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Interest Coverage Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Interest Coverage distribution charts can be found below:

* The bar in red indicates where PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Interest Coverage falls into.


;
;

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Interest Coverage for the fiscal year that ended in Dec. 2024 is calculated as

Here, for the fiscal year that ended in Dec. 2024, PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Interest Expense was MAD-10.2 Mil. Its Operating Income was MAD96.3 Mil. And its Long-Term Debt & Capital Lease Obligation was MAD0.0 Mil.

Interest Coverage=-1* Operating Income (A: Dec. 2024 )/Interest Expense (A: Dec. 2024 )
=-1*96.31/-10.152
=9.49

PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Here, for the six months ended in Dec. 2024, PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Interest Expense was MAD-5.6 Mil. Its Operating Income was MAD51.7 Mil. And its Long-Term Debt & Capital Lease Obligation was MAD0.0 Mil.

Interest Coverage=-1* Operating Income (Q: Dec. 2024 )/Interest Expense (Q: Dec. 2024 )
=-1*51.732/-5.572
=9.28

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM  (CAS:PRO) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Interest Coverage Related Terms

Thank you for viewing the detailed overview of PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM Business Description

Traded in Other Exchanges
N/A
Address
Rue N 7, ZI du Sahel, BP 96/97, Berrechid, Had Soualem, MAR, 26400
PROMOTION PHARMACEUTIQUE DU MAGHREB PROMOPHARM is engaged in production, marketing, import and export of pharmaceuticals, parapharmaceuticals, dermopharmaceuticals and cosmetics.